Prize4Life

Mobile App for Monitoring Disease Progression in People with ALS

Health Tech & Life Sciences
Non Active, Dec 2022 ceased to operate
Follow

Company Overview

Snapshot

Founded in January 2007 by Avichai Kremer and Andrea Marano, Prize4Life operates with 1–10 employees. The organization has raised $447.2K across five funding rounds. In November 2018, Avi Kremer, Founder of Prize4Life, joined The ALS Association Team, signaling a strategic alignment within the ALS research community.

Business overview

Prize4Life is an Israeli nonprofit organization dedicated to accelerating innovative treatments and cures for Amyotrophic Lateral Sclerosis (ALS). The company's core product is the ALS Mobile Analyzer, a smartphone application designed to objectively and accurately track disease progression in ALS patients through self-reports and performance tasks. This technology aims to advance ALS research by enabling large-scale functional data collection, facilitate tailored clinical care, and streamline clinical trials. Prize4Life operates within the Health Tech & Life Sciences sector, specifically focusing on Digital Healthcare and Patient Remote Monitoring, serving patients, doctors, and pharma companies globally and in Israel.

Strategic signal

In November 2018, Avi Kremer, the founder of Prize4Life, joined The ALS Association Team. This move indicates a significant strategic integration of Prize4Life's leadership and mission within a major ALS advocacy organization, suggesting a potential shift towards broader collaborative efforts in fighting the disease and validating the impact of Prize4Life's initiatives.

Log in to access full profile

Company Intelligence Q&A

What is Prize4Life's primary mission?
Prize4Life is a nonprofit organization founded in 2007 with the mission of accelerating innovative and groundbreaking treatments and cures for ALS.
What is the ALS Mobile Analyzer?
The ALS Mobile Analyzer is a revolutionary smartphone app developed by Prize4Life to monitor ALS patients by tracking self-reports and performance on tasks to evaluate disease progression. It aims to advance ALS research, facilitate tailored clinical care, and enable faster clinical trials.
When did Prize4Life announce the winners of the ALS Stratification Challenge?
In November 2015, Prize4Life, Sage Bionetworks, and DREAM announced the winners of the ALS Stratification Challenge.
What was a significant development for Prize4Life in 2018?
In November 2018, Avi Kremer, the founder of Prize4Life, joined The ALS Association Team, indicating a strategic collaboration and integration within the ALS community.
What was the outcome of the ALS Treatment Prize announced by Prize4Life?
In January 2017, Prize4Life announced the winner of a $1 Million ALS Treatment Prize, highlighting advancements in ALS research and potential gene therapy approaches.
Log in to access full profile